Literature DB >> 5543546

Prevention of postoperative thromboemboli by combined treatment with low-molecular-weight dextran and a proteinase inhibitor. A study with use of thromboelastogram.

D Kimche, S Eisenkraft.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5543546      PMCID： PMC1397141          DOI： 10.1097/00000658-197101000-00026

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  10 in total

1.  USE OF DEXTRAN TO PREVENT ARTERIAL AND VENOUS THROMBOSIS.

Authors:  J A MONCRIEF; J C DARIN; P C CANIZARO; R B SAWYER
Journal:  Ann Surg       Date:  1963-10       Impact factor: 12.969

2.  THE SURGICAL PATIENT ON ANTICOAGULANT THERAPY.

Authors:  C A OWEN; J A SPITTELL; J H THOMPSON
Journal:  Am J Cardiol       Date:  1963-09       Impact factor: 2.778

3.  USE OF ANTICOAGULANTS IN THE PREVENTION OF VENOUS THROMBOEMBOLIC DISEASE IN POSTOPERATIVE PATIENTS.

Authors:  H H BELDING
Journal:  Arch Surg       Date:  1965-04

4.  DEXTRAN IN THE TREATMENT OF THROMBOPHLEBITIS.

Authors:  E F COX; C T FLOTTE; R W BUXTON
Journal:  Surgery       Date:  1965-02       Impact factor: 3.982

5.  A plan of heparinization of the surgical patient to prevent postoperative thromboembolism.

Authors:  J G SHARNOFF; H H KASS; B A MISTICA
Journal:  Surg Gynecol Obstet       Date:  1962-07

6.  Anticoagulant prophylaxis of thromboembolism in postsurgical patients.

Authors:  R M Shepard; H A White; A L Shirkey
Journal:  Am J Surg       Date:  1966-11       Impact factor: 2.565

7.  Experimental investigations on the antithromboplastic and antifibrinolytic activity of Trasylol.

Authors:  S Nordström; B Blombäck; M Blombäck; P Olsson; E Zetterqvist
Journal:  Ann N Y Acad Sci       Date:  1968-06-28       Impact factor: 5.691

8.  Combined prophylaxis of haemorrhage and thrombosis after prostatectomy.

Authors:  L Andersson
Journal:  Acta Chir Scand       Date:  1965-10

9.  Dextran 75 and postoperative phlebitis. Evaluation of dextran 75 in the prophylaxis of postoperative thrombophlebitis, pulmonary embolism, and myocardial infarction.

Authors:  J W Hartshorn; S N Teale; M Faiz
Journal:  Arch Surg       Date:  1969-06

10.  Low-molecular-weight dextran (Rheomacrodex) in the treatment of severe vascular insufficiency after trauma.

Authors:  A H RATLIFF
Journal:  Lancet       Date:  1963-06-01       Impact factor: 79.321
  10 in total
  2 in total

1.  Monitoring heparin therapy with thromboelastography and activated partial thromboplastin time.

Authors:  B Y Lee; S Taha; F S Trainor; D Kavner; W J McCann
Journal:  World J Surg       Date:  1980-05       Impact factor: 3.352

2.  Heparin treatment in abruptio placentae.

Authors:  T R Martin; H C Read; M E Fraser
Journal:  Can Med Assoc J       Date:  1974-05-18       Impact factor: 8.262
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.